is cancer vaccine treatment worth the cost?, page-15

kBear, this is not entirely unlike the situation seen with TIS. Often these trials are initially conducted on people with "nothing to lose" from trying something new. In TIS's case they were treating patients whose only other resort was treatment by amputation. their product will really come into it's own when used to treat ulcer sites that have only just formed.

Where Prima will really excel is if an early detection method can be devised, such that only surgery and maybe direct radiotherapy is required at the initial cancer site, and Cvac treatment is used to encourage the immune system to fight off the possibility of metastasis.

I'm in at the moment, and am keen on the placement, but given wider market conditions, I'm wary of an impending storm that will drag everything down, regardless of fundamentals.